Back to DODGE & COX DODGE & COX

NBIXNBIX
Showing 8 of 11 quarters

Position history for DODGE & COXDODGE & COX's holdings in NEUROCRINE BIOSCIENCES INC

DODGE & COX holds 5.5M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $719.4M as of 2026-Q1. The position was decreased (-0.8% shares). NBIX represents 0.4% of DODGE & COX's portfolio.

Current Value

$719.4M

Current Shares

5.5M

Total Value Change

+$543.1M

Total Shares Change

+4.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
5.5M
-0.8%
$719.4M0.4%$131.14
0
2025-Q4
Decreased
5.5M
-0.9%
$781.2M0.4%$140.95
0
2025-Q3
Decreased
5.6M
-0.2%
$780M0.4%$140.27
0
2025-Q2
Increased
5.6M
+0.6%
$699.7M0.4%$125.42
38
2025-Q1
Increased
5.5M
+83.5%
$612.1M0.3%$113.16
58
2024-Q4
Increased
3M
+134.2%
$411.7M0.2%$137.06
60
2024-Q3
Increased
1.3M
+0.6%
$148.4M0.1%$115.06
30
2024-Q2
Increased
1.3M
+1.2%
$176.3M0.1%$137.67
37

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used